Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Masaki Yamagami0
Yuya Kasahara0
Tadashi Umemoto0
Masahito Shimojo0
Satoshi Obika0
Takao Suzuki0
Date of Patent
January 9, 2024
0Patent Application Number
172616530
Date Filed
July 31, 2019
0Patent Citations
Patent Primary Examiner
Patent abstract
Disclosed is an oligonucleotide or a pharmacologically acceptable salt thereof, wherein the oligonucleotide comprises at least one defined nucleoside structure, can bind to a human nSR100 gene and has human nSR100 expression inhibiting activity. The oligonucleotide has a length of 12 to 20 mer, and is complementary to a defined target region. Further, disclosed is an nSR100 gene expression inhibitor and a cancer therapeutic agent containing the oligonucleotide or the pharmacologically acceptable salt thereof. The cancer therapeutic agent is used for treatment of small cell lung cancer, prostate cancer, or breast cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.